Rhizomelic chondrodysplasia punctata morbidity and mortality, an update
- 25 November 2019
- journal article
- letter
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 182 (3) , 579-583
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Functions of plasmalogen lipids in health and diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Rhizomelic chondrodysplasia punctata type 1 and fulminant neonatal respiratory failure, a case report and discussion of pathophysiologyAmerican Journal of Medical Genetics Part A, 2011
- Functional characterization of novel mutations in GNPAT and AGPS, causing rhizomelic chondrodysplasia punctata (RCDP) types 2 and 3Human Mutation, 2011
- Natural history of rhizomelic chondrodysplasia punctataAmerican Journal of Medical Genetics Part A, 2003
- Mutation analysis ofPEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotypeHuman Mutation, 2002
- Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptorNature Genetics, 1997
- Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptorNature Genetics, 1997
- Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctataNature Genetics, 1997
- Birth prevalence rates of skeletal dysplasiasClinical Genetics, 1989
- Heterogeneity of Chondrodysplasia punctataHuman Genetics, 1971